VeteXema extends this scientific approach to veterinary dermatology, focusing on the management of inflammatory dermatoses in companion and farm animals.

Based on the same technological platform, its dedicated formulations in foam form, uses non-pathogenic bacterial components conjugated with mucopolysaccharides to modulate the skin microbiota and promote skin barrier restoration.

Designed to be used as stand alone treatment in mild to moderate and complement to systemic therapies, VeteXema solutions aim to reduce inflammation, improve skin condition, and increase animal well-being and quality of life.

The project is financed by three VCs

Aileens Pharma srl

REA no. MB – 2528092
VAT code 10396400961
Fully paid-up corporate capital €16.993

Contact Us

info@aileenspharma.com
Certified email address
aileenspharmasrl@legalmail.it

All Rights Reserved · web design shishi

©2026